Multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection: diagnosis and differential diagnosis

QR Code

Multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection: diagnosis and differential diagnosis

Multisystem inflammatory syndrome in children (MIS-C) is a new pediatric hyperinflammatory disease. Its prevalence is 0.69 cases per 1,000 SARS-CoV-2 infections, and the fatality rate is 1–2 %. There is an evolution in the criteria for its diagnosis. Today, in the updated criteria, the following sig...

Full description

Saved in:

Bibliographic Details
Main Authors:	O.P. Volosovets, S.P. Kryvopustov
Format:	Article
Language:	English
Published:	Zaslavsky O.Yu. 2025-03-01
Series:	Zdorovʹe Rebenka
Subjects:	covid-19 sars-cov-2 differential diagnosis children multisystem inflammatory syndrome in children
Online Access:	https://childshealth.zaslavsky.com.ua/index.php/journal/article/view/1793
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immunological criteria for the diagnosis of multisystem inflammatory syndrome associated with MERS-COV-2 and infectious diseases with sepsis in children
by: Yu. E. Konstantinovа, et al.
Published: (2024-12-01)

Features of laboratory parameters in children with multisystem inflammatory syndrome associated with SARS-CoV-2
by: O. O. Obukhova, et al.
Published: (2022-10-01)

Pediatric multisystem inflammatory syndrome associated with a new coronavirus infection: unresolved issues
by: Yu. V. Lobzin, et al.
Published: (2021-03-01)

Correction of microecological imbalance in children who have suffered from multisystem inflammatory syndrome associated with SARS‐CoV‐2 in the post‐rehabilitation period
by: T. I. Ryabichenko, et al.
Published: (2024-07-01)

The clinical manifestation and diagnostic features of Kawasaki-like phenotypes in pediatric multisystem inflammatory syndrome: a comparative retrospective study in Ukraine
by: Nataliia Bodnarchuk-Sokhatska, et al.
Published: (2025-07-01)

Multisystem inflammatory syndrome (MIS) or Kawasaki-like syndrome associated with COVID-19
by: E. A. Besedina, et al.
Published: (2023-07-01)

Children’s Multisystem Inflammatory Syndrome, Associated With a New Coronavirus Infection (COVID-19): Relevant Information and Clinical Observation
by: Marina G. Kantemirova, et al.
Published: (2020-08-01)

Retrospective analysis of cases of multisystem inflammatory syndrome associated with COVID-19 infection in children in the Republic of Komi
by: N. N. Korableva, et al.
Published: (2023-07-01)

Factors Associated with COVID-19 Infection Related Multisystem Inflammatory Syndrome in Children: A Multicenter Matched Case-Control Study
by: Buddhaporn Prasertsakul, et al.
Published: (2025-05-01)

COVID-19 Dermatological Manifestations in Children
by: Vladislav V. Ivanchikov, et al.
Published: (2022-05-01)

Diagnostic features of multiple organic system disorders associated with COVID-19 in a child of primary school age
by: S. G. Fetisova, et al.
Published: (2023-01-01)

Challenges of Timely Kawasaki Disease Diagnosis in 2-Month-Old Child: Clinical Case
by: Yuliya A. Ermolaeva, et al.
Published: (2025-02-01)

Pediatric Multisystem Inflammatory Syndrome in a Patient with a Coma with a Hyperosmolar Component in the Manifestation of Type 1 Diabetes Mellitus: Clinical Case
by: Anastasia N. Lazareva, et al.
Published: (2024-09-01)

Durability of Antibody Responses to SARS-CoV-2 Vaccination over 12 Months in Pediatric Inflammatory Bowel Disease
by: Sally J. Lawrence, et al.
Published: (2025-05-01)

Hand osteoarthritis: Differential diagnosis with inflammatory joint diseases and treatment policy
by: Yu. A. Olyunin
Published: (2016-01-01)

Coronavirus Desease 2019 (COVID-19) in Children: Lessons from Pediatric Rheumatology
by: M. I. Kaleda, et al.
Published: (2020-11-01)

Pneumococcal Septicemia after COVID-19 in Teenager: Clinical Case
by: Viktor V. Krasnov, et al.
Published: (2021-10-01)

The Influence of Traumatic Injuries Early Diagnosis on the Development of Pulmonary Complications in Patients With Multisystem Chest Trauma
by: E. S. Vladimirova, et al.
Published: (2022-01-01)

Age-Specific Clinical and Laboratory Features and Renal Involvement in Children with MIS-C: A Single Tertiary Centre Experience from Vojvodina
by: Borko Milanović, et al.
Published: (2025-06-01)

Multisystem atrophy: clinical manifestations, pathogenesis questions
by: T. A. Valikova, et al.
Published: (2010-08-01)

Practical Challenges in the Diagnosis of SARS-CoV-2 Infection in Children
by: Alina Petronela Bouari-Coblișan, et al.
Published: (2025-05-01)

Development and Validation of ELISA for In Vitro Diagnosis of SARS-CoV-2 Infection
by: Larissa de Carvalho Medrado Vasconcelos, et al.
Published: (2025-07-01)

Interaction of SARS-CoV-2 and SARS-CoV-2 vaccines with renin angiotensin aldosterone system, clinical outcomes, and angiotensin (1-7) as a physiological treatment recommendation: hypothesis and theory article
by: Ali Rıza Aktaş
Published: (2025-07-01)

Rosai–Dorfman disease presenting as a scleral nodule in a female with multisystem inflammatory syndrome post-COVID-19 infection
by: Nashra Alma, et al.
Published: (2025-04-01)

Difficulties of differential diagnosis of skin pathology in newborn. Clinical observation
by: T. I. Pozhidaeva, et al.
Published: (2022-10-01)

Comprehensive insights into the therapeutic effects of baicalein and baicalin against SARS-COV-2 infection
by: Cheng-Han Lin, et al.
Published: (2025-08-01)

Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01)

Validity and Reliability of Clinical and Patient‐Reported Outcomes in Multisystem Proteinopathy 1
by: Lindsay N. Alfano, et al.
Published: (2025-07-01)

Multisystem Abdominal Trauma in Pregnancy: Multidisciplinary Approach to Diagnosis and Treatment
by: V. V. Aleksandrov, et al.
Published: (2022-01-01)

DIFFICULTIES IN DIFFERENTIATED DIAGNOSIS OF LUNG CANCER AND INFLAMMATORY CHANGES IN LUNG TISSUE
by: Z. V. Grigorievskaya, et al.
Published: (2018-11-01)

Vaccination against the SARS-CoV-2 in individuals with comorbidities
by: S A Berns, et al.
Published: (2025-02-01)

Assessment of the therapeutic effect of the drug Molixan in the treatment of Syrian hamsters experimentally infected with the SARS-CoV-2 virus
by: M. A. Gulyaeva, et al.
Published: (2024-06-01)

Structural proteins of SARS-CoV-2
by: O. V. Duvanova, et al.
Published: (2023-01-01)

The Coronavirus SARS-Cov-2: the Complexity of Infection Pathogenesis, the Search of Vaccines and Possible Future Pandemics
by: E. P. Kharchenko
Published: (2020-07-01)

Diaphragmatic Injury in Multisystem Closed Abdominal Trauma: Features of Diagnosis and Treatment
by: V. V. Aleksandrov, et al.
Published: (2022-04-01)

International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of 1,000 patients
by: G. P. Arutyunov, et al.
Published: (2020-12-01)

Gravitational Erythema: Case Study and Differential Diagnosis
by: Nina T. Garipova, et al.
Published: (2020-02-01)

Clinical case severe course of coronavirus infection (COVID-19) in a child
by: H.B. Mateiko, et al.
Published: (2023-03-01)

Fatty Acids of Erythrocyte Membranes and Blood Serum in Differential Diagnosis of Inflammatory Bowel Diseases
by: M. V. Kruchinina, et al.
Published: (2022-12-01)

Statement on Management of Children with Allergic Diseases During New Coronaviral Infection SARS-CoV-2 Pandemic (COVID-19 Infection)
by: Alexander A. Baranov, et al.
Published: (2020-06-01)